CME

CME Group
D

CME

Arincen73/100B
319.28
USD
3.57
(1.13%)
Market Open
Last updated: · Delayed 15 min
Fair value297.15Plus+7%228Price 319.28499
Q4 FY2026 · Earnings report
EPS estimate 3.01Revenue estimate 1.76B
OverviewFinancialsSignalsForecastEarningsDividendsCompany

CME Group EPS (earnings per share) 2000–2026

CME Group's diluted EPS in Q3 FY2026, the three months to 30 September 2026, was 2.89 USD, up 16.1% on the same quarter a year before. CME Group's diluted earnings per share over the last twelve months were 12.19 USD, up 18.1% on the twelve months before. In fiscal year 2025 they were 11.16 USD, up 15.4% on the year before.

Last updated 8 Nov 2026 · Next report 3 Feb 2027

EPS

Growth

Fiscal yearPeriod endingEPSGrowthEPS (basic)
TTM30 Sept 202612.19+18.12%12.26
FY202531 Dec 202511.16+15.41%11.18
FY202431 Dec 20249.67+9.14%9.69
FY202331 Dec 20238.86+19.73%8.87
FY202231 Dec 20227.40+1.51%7.41
FY202131 Dec 20217.29+24.19%7.30
FY202031 Dec 20205.87-0.68%5.88
FY201931 Dec 20195.91+3.50%5.93
FY201831 Dec 20185.71-52.18%5.73
FY201731 Dec 201711.94+163.58%12.00
FY201631 Dec 20164.53+22.76%4.55
FY201531 Dec 20153.69+10.15%3.71
FY201431 Dec 20143.35+14.73%3.37
FY201331 Dec 20132.92+8.15%2.94
FY201231 Dec 20122.70-50.28%2.71
FY201131 Dec 20115.43+89.86%5.45
FY201031 Dec 20102.86+15.32%2.87
FY200931 Dec 20092.48+2.06%2.49
FY200831 Dec 20082.43-18.73%2.44
FY200731 Dec 20072.99+28.88%3.01
FY200631 Dec 20062.32+31.82%2.35
FY200531 Dec 20051.76+37.50%1.79
FY200431 Dec 20041.28+77.78%1.31
FY200331 Dec 20030.72+14.29%0.75
FY200231 Dec 20020.63+34.04%0.65
FY200131 Dec 20010.47—0.47
FY200031 Dec 2000-0.04—-0.04

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about CME Group's EPS

Source: Financial Modeling Prep